Video from ECR 2019: Alexander Radbruch on gadolinium debate

March 1, 2019

VIENNA - The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments in gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.

Video loading ...

Dr. Alexander Radbruch, JD, from Essen, Germany.

Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at

If you like this content, please share it with a colleague!

Related Reading

German study may offer new way to detect gadolinium
Researchers from Germany are mulling the possibility that significantly lower T1 relaxation times may indicate the presence of gadolinium in the brains...

Video from RSNA 2018: Dr. Emanuel Kanal on gadolinium safety
CHICAGO - One of the foremost authorities on gadolinium safety is Dr. Emanuel Kanal of the University of Pittsburgh. We discuss what's currently...

Video from RSNA 2018: What do we know about gadolinium deposition?
CHICAGO - New findings are coming out on almost a weekly basis about trace elements of gadolinium left in human tissue after scans with MRI contrast agents....

Video from ECR 2018: Alexander Radbruch on gadolinium retention
VIENNA - The debate over the safety of gadolinium-based contrast agents for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists...

Safety issues linger over gadolinium-based contrast agents
Conclusive research into the safety of gadolinium-based contrast agents could take about a decade to emerge because of the huge difficulties of obtaining...